Table 2.
Prevalence of Hepatotropic Viruses in AVH.
| Viral markers | AVH pregnant (411) | AVH nonpregnant (357) | P value |
|---|---|---|---|
| HAV IgM | 13 (3.16%) | 44 (12.32%) | <0.001 |
| HBsAg | 39 (9.48%) | 77 (21.56%) | <0.001 |
| Anti-HCV | 11 (2.67%) | 7 (1.96%) | 0.67 |
| HEV IgM | 340 (82.72%) | 155 (43.41%) | <0.001 |
| Non–A-E | 8 (1.94%) | 74 (20.72%) | <0.001 |
AVH, acute viral hepatitis; HAV IgM, hepatitis A virus immunoglobulin M; HBsAg, hepatitis B′s antigen; HCV, hepatitis C virus; HEV IgM, hepatitis E virus immunoglobulin M; non–A-E, non–adverse events.